太龙药业 (600222.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(太龙药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2022年一季报2021年年报2021年三季报2021年中报2021年一季报2020年年报2020年三季报2020年中报2020年一季报
主要指标:
 营业收入(元) 422,282,414.891,604,516,940.001,117,873,585.28751,871,898.69415,958,437.101,417,097,311.59965,229,694.68647,757,181.42406,482,770.63
 营业利润(元) 2,976,218.2435,607,981.9229,350,646.6323,812,506.6230,641,135.9332,989,127.4438,749,487.1337,172,181.4546,723,625.97
 利润总额(元) 2,947,733.157,450,043.9535,568,978.6730,795,627.9930,620,007.6429,239,738.3135,531,381.6034,056,117.9743,677,278.35
 净利润(元) 2,166,570.196,778,638.9329,135,082.7628,002,133.9426,632,438.7927,595,800.4729,268,070.7027,938,070.6836,999,296.41
 归属于母公司股东的净利润(元) 2,329,695.735,995,375.5528,299,147.7527,181,631.5326,863,537.7929,240,862.3929,499,856.7728,178,558.5337,397,592.99
盈利能力:
 销售毛利率(%) 30.5628.8628.3828.2229.8726.4535.5136.5038.58
 销售净利率(%) 0.510.422.613.726.401.953.034.319.10
 净资产收益率(%) 0.140.391.861.801.77----
 总资产报酬率ROA(%) 0.552.552.942.261.54----
 投入资本回报率ROIC(%) 0.080.210.980.960.941.121.171.121.49
营运能力:
 存货周转率(次) 0.763.132.331.680.91----
 应收账款周转率(次) 0.723.181.961.360.81----
 总资产周转率(次) 0.110.450.320.230.13----
偿债能力:
 资产负债率(%) 49.7353.0255.3150.5351.7754.8452.9451.8852.10
 股东权益比率(%) 46.0843.8942.0446.2245.1442.8846.9848.0447.83
 已获利息倍数(倍) 1.171.091.541.732.541.431.762.093.51
 流动比率 1.171.181.181.231.311.252.121.891.94
 速动比率 0.840.880.880.951.020.971.711.471.53
发展能力:
 营业收入增长率(%) 1.5213.2315.8016.072.338.038.649.2149.39
 营业利润增长率(%) -90.297.94-10.46-31.55-31.18-34.72-3.518.53168.30
 税后利润增长率(%) -91.33-79.5012.451.62-24.92-34.16-10.377.49190.28
 净资产增长率(%) 3.4514.2514.1426.3425.355.708.752.110.59
 总资产增长率(%) 1.3411.6427.5731.3132.8015.6315.466.061.74

前瞻产业研究院